Medical directoryActive ingredient
Liraglutide
A once-daily GLP-1 receptor agonist that predates semaglutide. Licensed for type 2 diabetes and for weight management, depending on the presentation.
Content reviewed by Dr. David Céspedes
Medical guides
Mounjaro reviews: what the trials show and what patients report
ReadHow much does Mounjaro cost per month in Spain: the real price per dose in 2026
ReadOrforglipron (Foundayo), approved by the FDA: the first GLP-1 pill that can be taken without food or water restrictions
ReadGLP-1: what it is, how it works and why it is transforming obesity treatment
ReadMounjaro vs Ozempic: clinical differences, effectiveness and which one suits you
Read
Keep reading
This entry is for information. Your case requires an individual medical assessment.